πŸ‡ΊπŸ‡Έ FDA
Patent

US 8703726

Methods for treating prostate conditions

granted A61KA61K31/44A61P

Quick answer

US patent 8703726 (Methods for treating prostate conditions) held by PTC THERAPEUTICS, INC. expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PTC THERAPEUTICS, INC.
Grant date
Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/44, A61P, A61P35/00